← FDA DRUG APPROVALS

FDA ANDA · ANDA087277

ACETAMINOPHEN AND CODEINE PHOSPHATE

Sponsor: WATSON LABS

APPLICATION
ANDA087277
TYPE
ANDA
ORIGINAL APPROVAL
1982-05-26
LATEST ACTION
1989-03-27
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

ACETAMINOPHEN AND CODEINE PHOSPHATEDiscontinued
ACETAMINOPHEN 300MG, CODEINE PHOSPHATE 15MG · TABLET · ORAL

Approval history

1989-03-27Labeling · Supplement 29AP
1988-12-16Labeling · Supplement 22AP
1982-05-26OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →